BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Laser capture microdissection
,
Doxycycline
,
rs7903146
,
TGFB1
,
HIV infection
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
t 107
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Biological pathways of Hsp90 inhibitors 17-AAG and 17-DMAG in adult T cell leukemia cell lines
Polysomal RNA from 483 T-ALL cells treated with cap-dependent translation inhibitor
Jurkat cells analyzed for miR-21 targets by AGO2 immunoprecipitation
T-cell acute lymphoblastic leukemic cells treated with 4EGI1 - polysomal & cytoplasmic RNA fractions
T-cell acute lymphoblastic leukemia Jurkat E6-1 cells with MALAT1 knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
The effect of paraoxonase 1 (PON1) gene polymorphisms T(-107)C and L55M and diet composition on seru…
The effect of the paraoxonase 1 (PON1) T(-107)C polymorphism on serum PON1 activity in women is depe…
AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH recept…
Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizi…
Luteinizing hormone-releasing hormone receptor targeted agents for prostate cancer.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
Study of Intravenous RXDX-107 in Patients With Solid Tumors
Study With CIN-107 Following Multiple Oral Ascending Doses in Healthy Subjects
Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In H…
Autologous Cells Derived Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ